• Pathological complete response to pembrolizumab in dMMR CRC despite radiological residual disease

    A case report describes a 70-year-old man with dMMR sigmoid colon cancer and liver metastases who achieved pathological complete response in both primary and metastatic lesions after preoperative pembrolizumab, despite imaging suggesting residual tumor. (Cureus)